Bausch + Lomb Names Thomas Appio Interim CEO; Expects to Raise 2026 Guidance

07:25 AM EDT, 10/12/2026 (MT Newswires) -- Bausch + Lomb (BLCO) said Monday it has appointed Bausch Health (BHC) CEO Thomas Appio as interim chief executive officer, effective immediately. He succeeds Brent Saunders, who will depart by mutual agreement with the board, the company said. Appio will retain his role as Bausch Health CEO while leading Bausch + Lomb, according to a company statement. Additionally, Bausch + Lomb said it and Bausch Health plan to raise full-year 2026 adjusted EBITDA excluding acquired in-process research and development, or IPR&D, guidance based on preliminary Q3 results. The company said it plans to provide more details when it reports its Q3 financial results on Oct. 28.